Peptide directoryBrain, hypothalamus & pituitary

Prolactin-releasing peptide-31

The full-length PrRP, more potent than its short form.

Where it comes from

Made in
The same brainstem and hypothalamic neurons as PrRP-20
Sent out by
With PrRP-20; the two are cut from one precursor
Acts on
  • Hypothalamus
  • Brainstem

What it does

  • Suppresses feeding and raises blood pressure as PrRP-20 does, somewhat more potently 1
  • Carries satiety from the brainstem to the hypothalamus after a meal, alongside CCK 2
  • Takes part in the stress response by acting on CRH neurons of the paraventricular nucleus 2

In medicine

  • None of its own; no PrRP-31 medicine or clinical assay exists
  • Telling the two forms apart is the practical difficulty, because most antibodies recognise the shared amidated tail, so a reported PrRP level usually means both 2

Beyond the body’s own use

  • No human trial; what is known comes from rodents given the peptide into the brain or the bloodstream 2
  • PrRP-31 is the form the lipidised anti-obesity analogues were built from, and those reduced weight and improved glucose tolerance across several rodent models of obesity and metabolic syndrome 3
  • Whether the two forms do different jobs is unsettled. Both act on GPR10, PrRP-31 rather more strongly, and no tool selective for one of them exists 1

Sources

  1. Hinuma et al., A prolactin-releasing peptide in the brain, Nature 1998
  2. Dodd & Luckman, Physiological roles of GPR10 and PrRP signalling, Frontiers in Endocrinology 2013
  3. Mráziková et al., Lipidized prolactin-releasing peptide in obesity and type 2 diabetes, Frontiers in Pharmacology 2021

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.